RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Methodological Considerations for the Implementation of A European Mandated Retrospective Drug Utilisation Study (Dus) to Investigate the Use of Dexmedetomidine (Dexdor(R)) in Clinical Practice
Stein, D., Weatherall, M., Garratt, C., Aantaa, R., Conti, G., Lewis, MA., Moore, N., & Perez-Gutthann, S. (2015). Methodological Considerations for the Implementation of A European Mandated Retrospective Drug Utilisation Study (Dus) to Investigate the Use of Dexmedetomidine (Dexdor(R)) in Clinical Practice. Value in Health, 18(7), A723. https://doi.org/10.1016/j.jval.2015.09.2746
